Compound Detail
CHEMBL386421
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL386421 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RVXJMTPOPBDAPQ-UHFFFAOYSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
377.3
MW (Da)
3.70
ALogP
5
HBA
1
HBD
77.2
PSA (Ų)
0.71
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 4.96
IC50 1 meas. best 5.54
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Egl nine homolog 1 CHEMBL5697 | IC50 | 5.54 | 5.54 | 2900.0 | 1 |
| HEK293 CHEMBL614818 | EC50 | 4.96 | 4.96 | 11000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Egl nine homolog 1 | IC50 | = | 2900.0 | nM | 5.54 | Inhibition of human EGLN1 | 16908145 |
| HEK293 | EC50 | = | 11000.0 | nM | 4.96 | Induction of human VEGF in HEK293 cells | 16908145 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16908145 | 10.1016/j.bmcl.2006.08.017 | Egl nine homolog 1 | 1 |
| 16908145 | 10.1016/j.bmcl.2006.08.017 | HEK293 | 1 |
Data from ChEMBL 36 via Core Engine